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Background: Osteoprotogerin (OPG) and osteopontin (OPN) has recently emerged as key factor in both vascular remodeling and development of 
atherosclerosis. The study was designed to evaluate the relation between serum concentration of OPG and OPN, arterial function and the presence 
and severity of coronary artery disease (CAD).
Methods: The study population consisted of 409 subjects undergoing diagnostic coronary angiography for suspected CAD. Diagnostic coronary 
angiography categorized subjects in the group of CAD, 280 patients with 1 vessel disease (1VD) or multivessel (2VD, or 3VD) CAD (mean aged 
61±11years), and in the control group, 129 healthy subjects (mean aged 60±12 years). Serum OPG and OPN levels were measured, by ELISA. 
Endothelial function was evaluated by flow mediated dilation (FMD) in the brachial artery and carotid-femoral pulse wave velocity (PWV) was 
measured as an index of aortic stiffness.
Results: CAD patients had significantly impaired FMD (p<0.001), increased PWV (p=0.006), increased OPG (p<0.001) and logOPN levels 
(p<0.001) compared to control subjects. In CAD patients PWV was positively associated with serum OPG levels (r=0.19, p<0.01) and logOPN levels 
(r=0.10, p=0.049). Moreover, in CAD patients FMD was negatively associated with OPG levels (r=-0.126, p=0.048). Furthermore, analysis of variance 
revealed that OPG (1VD:3.75±1.76 vs. 2VD:3.41±1.68 vs. 3VD:4.48±2.15 pmol/l, p=0.006) and logOPN (1VD:1.82±0.18 vs. 2VD:1.76±0.18 
vs. 3VD: 1.88±0.22 pmol/l, p=0.002) levels were associated with the extend of CAD. The association of OPG levels with multivessel CAD was 
also confirmed by ROC curve analysis, where OPG levels have sufficient discriminating ability to detect 3VD in patients suspected for CAD before 
undergoing diagnostic coronary angiography (AUC=0.644, 95% CI: 0.564, 0.723, p=0.001), while the best discriminate value of OPG to detect 3VD 
was assessed at 4.46 pmol/l with a sensitivity of 57% and a specificity of 70%.
Conclusion: Arterial function is correlated with OPG and OPN serum levels in CAD patients. Moreover, increased OPG and OPN levels are 
associated with multivessel CAD and increased OPG levels can possibly predict multivessel CAD.
